FLSM
ZLAB icon

Frazier Life Sciences Management’s Zai Lab ZLAB Stock Holding History

Frazier Life Sciences Management’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.1M Hold
1,902,320
– – 0.79% 26
2026
Q1 		$35.8M Hold
1,902,320
– – 0.92% 22
2025
Q4 		$33.6M Buy
1,902,320
+275,000
+17% +$6.44M 0.9% 24
2025
Q3 		$55.1M Buy
1,627,320
+319,182
+24% +$11M 1.65% 14
2025
Q2 		$45.7M Buy
1,308,138
+958,138
+274% +$31.5M 1.83% 14
2025
Q1 		$12.6M Buy
+350,000
New +$10.8M 0.58% 31

Other funds holding ZLAB

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Frazier Life Sciences Management's ZLAB Position: Q2 2026 in Review

Frazier Life Sciences Management held its Zai Lab (ZLAB) position steady in Q2 2026 at 1,902,320 shares worth $36.1M. The position accounts for 0.79% of the portfolio, ranked #26.

Frazier Life Sciences Management first reported a position in ZLAB in Q1 2025 and has held it in 6 quarters since. The position peaked at $55.1M in Q3 2025. 93 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

  • Frazier Life Sciences Management held 1,902,320 shares of Zai Lab worth $36.1M as of Q2 2026.
  • Frazier Life Sciences Management left its Zai Lab share count unchanged in Q2 2026.
  • Zai Lab made up 0.79% of Frazier Life Sciences Management's portfolio in Q2 2026, its #26 holding.
  • Frazier Life Sciences Management first reported a position in Zai Lab in Q1 2025 and has held it in 6 quarters since.
  • Frazier Life Sciences Management's Zai Lab position peaked at $55.1M in Q3 2025.
  • 93 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on Frazier Life Sciences Management's 13F filing for Q2 2026, filed 14 Aug 2026.